Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data by Albert J. Farias, Wen-Hsing Wu, Xianglin L. Du

Get full text

Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma by Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, Evgeny Degtyarev, Lisa V Hampson, Aisha Masood, Wen-Hsing Wu

Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC by Bruce E. Johnson, MD, Christina S. Baik, MD, Julien Mazieres, MD, Harry J.M. Groen, MD, Barbara Melosky, MD, Jürgen Wolf, MD, Fatemeh Asad Zadeh Vosta Kolaei, PhD, Wen-Hsing Wu, MS, Stefanie Knoll, PhD, Meryem Ktiouet Dawson, MD, Adam Johns, PhD, David Planchard, MD

Get full text